MedTrace Logo

Evaluation of Visual Outcomes of Monovision Patients Bilaterally Implanted With Nanoflex Intraocular Lenses

NCT01279122 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-02-17

No results posted yet for this study

Summary

The purpose of this study is to look at how well you see the Nanoflex Intraocular lens placed in your eye.

Conditions

  • Patients Who Have Bilateral NanoFlex Implantation at Least 3 Months Previously

Interventions

DEVICE

Nanoflex IOL

Patients who were implanted with the Nanoflex IOL

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01279122 on ClinicalTrials.gov